Germany· DE-A57-e689733e4b87ec53
Levetiracetam Ethypharm
A levetiracetam product containing levetiracetam, registered in Germany by Altan Pharmaceuticals S.A.. The same ATC class is registered in 19 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Levetiracetam is registered in 19 of 19 countries.
Countries holding a registration under ATC N03AX14 (levetiracetam), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 11 of them publish a price we can compare per daily dose
Levetiracetam · ATC N03AX14
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of levetiracetam costs, country by country.
Normalised to the WHO defined daily dose (1.5 g), the median price runs from $1.19 in France to $3.10 in Spain — a ×2.6 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Levetiracetam · price per daily dose (1.5 g)
USD · FX 28 Sept 2026
- ES Spain$3.10
- CH Switzerland$2.54
- IT Italy$2.14
- FR France$1.19
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Levetiracetam
- Manufacturer
- Altan Pharmaceuticals S.A.
- Country
- Germany (DE)
- ATC code
- N03AX14
- ATC class
- Levetiracetam
- Defined daily dose
- 1.5 g, O
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
258 interactions on record for levetiracetam.
Graded by severity as the source publishes them — 50 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Levetiracetam · interactions on record
258 records
- 50 moderate
- 3 minor
- 164 info
Most severe, free to view
- MetoclopramideA03FA01moderate
- DiphenhydraminA04AB05moderate
- DronabinolA04AD10moderate
- NabiloneA04AD11moderate
41 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Levetiracetam in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaDRETACENSandoz s.r.o., Praha
- United StatesELEPSIA XR 1000 MGTRIPOINT THERAPEUTICS, LLC
- United KingdomDesitrend 1000mg granules sachetsDesitin Pharma Ltd
- SpainEVEXIBAM 1.000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGIntas Third Party Sales 2005 S.L.
- SwedenKeppra 100 mg/ml Koncentrat till infusionsvätska, lösningUCB Pharma S.A.
- SwitzerlandKeppra
- BelgiumKeppra 750 mgPI Pharma
- NetherlandsDRETACEN 1000 mg, filmomhulde tablettenSandoz B.V.
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Levebon, Levetiracetam +pharma
- Belgium · Larofec, Levetiracetam A.Forall
- Bulgaria · Levebon, Леветиракон Pharmacons
- Cyprus · Levetiracetam Noridem, Lyberen
- Czechia · Dretacen, Epiletam
- Denmark · Kevesy, Levetiracetam ”1a Farma”
- Estonia · Levetiracetam Zentiva, Normeg
- Spain · Laurak, Levetiracetam Almus
- Finland · Larofec, Levetiracetam 1a Farma
- France · Levetiracetam Accord, Levetiracetam Aguettant
- United Kingdom (Northern Ireland) · Desitrend, Genlev
- Greece · Ession, Kepricet
- Croatia · Levetiracetam Kalceks, Lyvam
- Hungary · Epiletam, Levetiracetam Kabi
- Ireland · Larofec, Levetiracetam Brillpharma
- Iceland · Keppra, Levetiracetam Accord
- Italy · Epitiram, Grifoxina
- Liechtenstein · Keppra, Levetiracetam Accord
- Lithuania · Dretacen, Levetiracetam Kalceks
- Luxembourg · Larofec, Levetiracetam Micro Labs
- Latvia · Levetiracetam Kalceks
- Malta · Levetiracetam Accord, Levetiracetam Aurobindo
- Netherlands · Dretacen, Larofec
- Norway · Keppra, Larofec
- Poland · Cezarius, Lepsitam
- Portugal · Cinaz, Laurak
- Romania · Levetiracetam Accord, Levetiracetam Arena
- Sweden · Levebon, Levetiracetam
- Slovenia · Levetiracetam Kalceks
- Slovakia · Epiletam, Levetiracetam
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c6654198-039a-4ad0-b19e-26d590df042f GET /v1/drugs/c6654198-039a-4ad0-b19e-26d590df042f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intravenous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Levetiracetam",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about levetiracetam.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.